# Efficacy, Safety and Pharmacokinetic Study of CPL500036 in Patients with Levodopa Induced Dyskinesia

> **NCT05297201** · PHASE2 · COMPLETED · sponsor: **Celon Pharma SA** · enrollment: 105 (actual)

## Conditions studied

- Parkinson Disease
- Dyskinesia, Medication-Induced

## Interventions

- **DRUG:** CPL500036 - low dose
- **DRUG:** CPL500036 - high dose
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05297201
- **Lead sponsor:** Celon Pharma SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-02
- **Primary completion:** 2025-01-13
- **Final completion:** 2025-01-27
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2025-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05297201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05297201, "Efficacy, Safety and Pharmacokinetic Study of CPL500036 in Patients with Levodopa Induced Dyskinesia". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05297201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*